Navigation Links
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting
Date:3/22/2011

for the year ended December 31, 2010 filed with the Securities and Exchange Commission, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements. These forward looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
2. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
3. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
4. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
5. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
6. Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care
7. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
8. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
9. Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study
10. iTherX Initiates Phase 1b Study of First-in-Class Hepatitis C Virus Entry Inhibitor ITX-5061
11. N30 Pharmaceuticals to Present S-Nitrosoglutathione Reductase Inhibitor Preclinical Safety Data at 2011 Society of Toxicology 50th Anniversary Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 16, 2015 Research and Markets ... the "The Corporate Reputation of Pharma - ... " report to their offering. ... is now in its fourth edition. This report ... 2015). For each annual Corporate Reputation report, the ...
(Date:4/16/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... of products for the treatment of central nervous system ... first quarter of 2015 on Wednesday, May 6, 2015, ... will host a conference call at 4:30 PM ET ... will discuss the first quarter 2015 financial results and ...
(Date:4/16/2015)... Calif. , April 16, 2015  Amgen (NASDAQ: ... its first quarter financial results on Tuesday, April 21, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... Olympus, a precision technology leader designing and delivering ... Medical and Surgical Products, Life Science Imaging Systems, ... Audio Products, has announced the call for nominations ... The national program, executed in partnership with the ...
... CID s.r.l., a European company leader in interventional ... their revolutionary drug eluting stent technology during The Drug ... on Wednesday, September 22, 2010.  The lecture, entitled "Status ... delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention ...
Cached Medicine Technology:Olympus Launches 2011 National Innovation Awards Program 2Olympus Launches 2011 National Innovation Awards Program 3Olympus Launches 2011 National Innovation Awards Program 4CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010 2
(Date:4/17/2015)... Jacksonville, Fla. (PRWEB) April 17, 2015 ... Cancer Center have signed a partnership agreement designed to ... , The institutions have agreed to create a ... Anderson’s treatment protocols and translational research. Baptist MD Anderson ... of 2015, providing a single destination for highly coordinated, ...
(Date:4/17/2015)... April 17, 2015 Scientists from ... multicenter team of U.S. and Venezuelan researchers, have ... in humans among an isolated tribe of Yanomami ... Bacterial diversity in the Yanomami, previously unexposed to ... nearly double that of people living in industrialized ...
(Date:4/17/2015)... TX (PRWEB) April 17, 2015 Connie ... specialist and functional medicine advocate with 30 years of ... will be adding another level of service for her ... her website of 10 recommended wellness books with a ... When asked to explain her interest in providing this ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Compare-autoinsurance.org has ... the best online auto insurance quotes . ... appropriate financial coverage for their cars. Drivers should always ... to buy. The insurance market is a competitive one, ... offers every hour. , It is now possible ...
(Date:4/17/2015)... 2015 Oxytocin is a ... and thought to help mothers bond to their newborn, ... substantiate this, new studies performed, at NYU Langone Medical ... reported by Medical News Today on April 16, 2015, ... maternal social behavior. The study reveals that, when oxytocin ...
Breaking Medicine News(10 mins):Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:The Best Auto Insurance Quotes Are Available Online! 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... treatments for heart disease, other conditions , MONDAY, Feb. ... that can change the way cells convert nutrients into ... heart attack, stroke and other conditions. , "Shifts in ... and in response to demanding activities -- like sprinting ...
... , Additional Grants and Donations Total ... and CLEARWATER, Fla. , Feb. 15 Catholic Health ... to support Global Health Ministry,s relief efforts in Haiti . ... use the funds to help rebuild the Hospital St. Francis de Sales ...
... , THE WOODLANDS, Texas , Feb. 15 ... the nation,s largest network including more than 1,300 oncologists and more than ... honored on Feb. 6 , by Texas Governor Rick Perry ... in El Paso, Texas . US Oncology was honored as an ...
... ... forum , ... February 14, 2010 -- Hayes, Inc., the nation’s leading health technology research and consulting ... Technology Research and Consulting, has joined the Medicare Evidence Development and Coverage Advisory Committee ...
... acyclovir is not a replacement for HIV-specific drugs, researchers say ... that people who are infected with both HIV-1, a strain ... could benefit in more than one way by taking a ... medication appears to also slow the progression of HIV. ...
... , , , , BEIJING , ... leading China -based vaccine manufacturer, today announced the completion by,its ... The total consideration for the purchase is approximately RMB120,million ... The,initial payment of RMB56.5 million ( $8.3 million ) ...
Cached Medicine News:Health News:Drugs That Shift Cell's Energy Find New Purpose 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 3Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 4Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 2Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 3Health News:Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 3
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... Merit has a complete offering of ... Performa brands, these catheters are designed with ... shaft strength and better push-ability, and large ... in 4, 5, 6 and 7 French ...
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Medicine Products: